[
  {
    "ts": null,
    "headline": "One of the Largest Teacher Pension Funds in the U.S. Sold Nvidia, Tesla, and Apple and Piled Into a Popular Pharmaceutical Stock Up 395% Over the Last 5 Years",
    "summary": "It's always a good idea for retail investors to take a look at what professional investors are doing.  With the second quarter of 2025 now over a month old, many investment funds will soon begin disclosing what stocks they held at the end of the first quarter, essentially providing investors a glimpse of what they bought and sold.  It's a particularly interesting time to see how large institutional funds invested early in the year, given all of the volatility.",
    "url": "https://finnhub.io/api/news?id=5d392742071548b8224b9008d7e0baf3a5616626b914afc038cfb18b19b23e41",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746741900,
      "headline": "One of the Largest Teacher Pension Funds in the U.S. Sold Nvidia, Tesla, and Apple and Piled Into a Popular Pharmaceutical Stock Up 395% Over the Last 5 Years",
      "id": 134335670,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "It's always a good idea for retail investors to take a look at what professional investors are doing.  With the second quarter of 2025 now over a month old, many investment funds will soon begin disclosing what stocks they held at the end of the first quarter, essentially providing investors a glimpse of what they bought and sold.  It's a particularly interesting time to see how large institutional funds invested early in the year, given all of the volatility.",
      "url": "https://finnhub.io/api/news?id=5d392742071548b8224b9008d7e0baf3a5616626b914afc038cfb18b19b23e41"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly (NYSE:LLY) Announces Executive Changes To Drive Global Growth And Pipeline Advancement",
    "summary": "Eli Lilly (NYSE:LLY) recently announced leadership transitions, including new roles for Ilya Yuffa, Patrik Jonsson, and Kenneth Custer, marking a strategic shift aiming to expand its global market presence and enhance product reach. Over the past month, the company's stock appreciated by 7%, potentially reflecting investor confidence in its direction amid these changes. Strong quarterly financial results, with significant increases in sales and earnings, would have bolstered investor...",
    "url": "https://finnhub.io/api/news?id=4974837f3da11ceb0f869cc313eda3094f0c3b38c533f4b6ef6bc797c76ec14f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746725941,
      "headline": "Eli Lilly (NYSE:LLY) Announces Executive Changes To Drive Global Growth And Pipeline Advancement",
      "id": 134335778,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly (NYSE:LLY) recently announced leadership transitions, including new roles for Ilya Yuffa, Patrik Jonsson, and Kenneth Custer, marking a strategic shift aiming to expand its global market presence and enhance product reach. Over the past month, the company's stock appreciated by 7%, potentially reflecting investor confidence in its direction amid these changes. Strong quarterly financial results, with significant increases in sales and earnings, would have bolstered investor...",
      "url": "https://finnhub.io/api/news?id=4974837f3da11ceb0f869cc313eda3094f0c3b38c533f4b6ef6bc797c76ec14f"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly & Co. stock underperforms Thursday when compared to competitors",
    "summary": "Eli Lilly & Co. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=701656d75e9e7269d5c574a7c182ad1da189b6f939309877590fe8db56bf1f1c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746721860,
      "headline": "Eli Lilly & Co. stock underperforms Thursday when compared to competitors",
      "id": 134340035,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly & Co. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=701656d75e9e7269d5c574a7c182ad1da189b6f939309877590fe8db56bf1f1c"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Movers Now: AB InBev, Molson Coors, Eli Lilly, and More",
    "summary": "U.S. equities gained at midday when the U.S. and U.K. struck a new trade deal.",
    "url": "https://finnhub.io/api/news?id=bb2ea0b74fd30449f517499c482574d3d8f74c11b55e876956d928a9844e0e39",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746719974,
      "headline": "Top Stock Movers Now: AB InBev, Molson Coors, Eli Lilly, and More",
      "id": 134327296,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "U.S. equities gained at midday when the U.S. and U.K. struck a new trade deal.",
      "url": "https://finnhub.io/api/news?id=bb2ea0b74fd30449f517499c482574d3d8f74c11b55e876956d928a9844e0e39"
    }
  },
  {
    "ts": null,
    "headline": "A Look at Pharma ETFs After Strong Q1 Earnings",
    "summary": "Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.",
    "url": "https://finnhub.io/api/news?id=268af555da3b9bc4ff0a37ee029804289b139cc81c8494abb1cab238bec319ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746719400,
      "headline": "A Look at Pharma ETFs After Strong Q1 Earnings",
      "id": 134335780,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.",
      "url": "https://finnhub.io/api/news?id=268af555da3b9bc4ff0a37ee029804289b139cc81c8494abb1cab238bec319ce"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Healthcare Fund Q1 2025 Commentary",
    "summary": "The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=1a3e772994eccdb6909ebaf690d19c5d6dc90778298d31e6e0056c9c40e64062",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746715560,
      "headline": "Hartford Healthcare Fund Q1 2025 Commentary",
      "id": 134328189,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1406458240/image_1406458240.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=1a3e772994eccdb6909ebaf690d19c5d6dc90778298d31e6e0056c9c40e64062"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly falls, Arm reacts to chip curbs, D-Wave skyrockets",
    "summary": "Eli Lilly (LLY) shares take a dip after Politico reports that President Trump will sign a new executive order around drug prices. Among chip stocks, Arm Holdings (ARM) slips lower after it was announced the Trump administration plans to repeal Biden-era curbs on AI chip exports. D-Wave Quantum (QBTS) stock surges by over 26% Thursday morning after the quantum computing company reported first quarter revenue soared by 509% year-over-year. Madison Mills and Truist Co-Chief Investment Officer and Chief Market Strategist Keith Lerner take a look at these top trending stocks. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.",
    "url": "https://finnhub.io/api/news?id=6e3430579cbe99323cf806846790db515a3dca22c3fd215de3854a19c2de86d9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746714993,
      "headline": "Eli Lilly falls, Arm reacts to chip curbs, D-Wave skyrockets",
      "id": 134325213,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly (LLY) shares take a dip after Politico reports that President Trump will sign a new executive order around drug prices. Among chip stocks, Arm Holdings (ARM) slips lower after it was announced the Trump administration plans to repeal Biden-era curbs on AI chip exports. D-Wave Quantum (QBTS) stock surges by over 26% Thursday morning after the quantum computing company reported first quarter revenue soared by 509% year-over-year. Madison Mills and Truist Co-Chief Investment Officer and Chief Market Strategist Keith Lerner take a look at these top trending stocks. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.",
      "url": "https://finnhub.io/api/news?id=6e3430579cbe99323cf806846790db515a3dca22c3fd215de3854a19c2de86d9"
    }
  },
  {
    "ts": null,
    "headline": "Post-Earnings Dip: Why This Beaten-Down Stock Is a No-Brainer Buy",
    "summary": "There is plenty of movement in equity markets during earnings season, but from a fundamental standpoint, investment theses seldom change.  Eli Lilly continues to deliver results that would make any megacap pharmaceutical company incredibly proud.  Its diabetes and obesity management medications did most of the heavy lifting, but older products, like cancer drug Verzenio, continue to perform well.",
    "url": "https://finnhub.io/api/news?id=58ae19af8d5fd7814e5b166278d9921bf28eb678e3fbf9f7a638a6d405dd9a49",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746709500,
      "headline": "Post-Earnings Dip: Why This Beaten-Down Stock Is a No-Brainer Buy",
      "id": 134325214,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "There is plenty of movement in equity markets during earnings season, but from a fundamental standpoint, investment theses seldom change.  Eli Lilly continues to deliver results that would make any megacap pharmaceutical company incredibly proud.  Its diabetes and obesity management medications did most of the heavy lifting, but older products, like cancer drug Verzenio, continue to perform well.",
      "url": "https://finnhub.io/api/news?id=58ae19af8d5fd7814e5b166278d9921bf28eb678e3fbf9f7a638a6d405dd9a49"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly's (NYSE:LLY) Solid Earnings Are Supported By Other Strong Factors",
    "summary": "Even though Eli Lilly and Company ( NYSE:LLY ) posted strong earnings, investors appeared to be underwhelmed. Our...",
    "url": "https://finnhub.io/api/news?id=bef9e4f5a6437c9ab33323bf49e0f2c90fe0863814fe72fc56ea064090f5c553",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746704232,
      "headline": "Eli Lilly's (NYSE:LLY) Solid Earnings Are Supported By Other Strong Factors",
      "id": 134325215,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Even though Eli Lilly and Company ( NYSE:LLY ) posted strong earnings, investors appeared to be underwhelmed. Our...",
      "url": "https://finnhub.io/api/news?id=bef9e4f5a6437c9ab33323bf49e0f2c90fe0863814fe72fc56ea064090f5c553"
    }
  },
  {
    "ts": null,
    "headline": "Lilly announces transitions in executive leadership",
    "summary": "Eli Lilly and Company (NYSE: LLY) today announced executive leadership transitions that will further enhance the company's ability to drive sustained, long-term growth and ensure that its medicines continue to reach millions of people worldwide.Lilly has experienced significant growth over the past several years, particularly in the U.S. and cardiometabolic health businesses. The company anticipates continued growth in these areas, along with further pipeline advancement. To help drive this next",
    "url": "https://finnhub.io/api/news?id=6fe0d15fdb9ba434e3c9985ad7362fc64403c3f1577dbe70af282d7cd2f4f9e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746701100,
      "headline": "Lilly announces transitions in executive leadership",
      "id": 134325216,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly and Company (NYSE: LLY) today announced executive leadership transitions that will further enhance the company's ability to drive sustained, long-term growth and ensure that its medicines continue to reach millions of people worldwide.Lilly has experienced significant growth over the past several years, particularly in the U.S. and cardiometabolic health businesses. The company anticipates continued growth in these areas, along with further pipeline advancement. To help drive this next",
      "url": "https://finnhub.io/api/news?id=6fe0d15fdb9ba434e3c9985ad7362fc64403c3f1577dbe70af282d7cd2f4f9e5"
    }
  },
  {
    "ts": null,
    "headline": "Energy stocks in the lead on Thursday; drugmakers weigh on healthcare",
    "summary": "Energy stocks in the lead on Thursday; drugmakers weigh on healthcare",
    "url": "https://finnhub.io/api/news?id=cc6f316656139ad3db1bb4f27dcf731396a3ccc2e0226af9f8197ed23a2dfcc0",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746698806,
      "headline": "Energy stocks in the lead on Thursday; drugmakers weigh on healthcare",
      "id": 134328681,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Energy stocks in the lead on Thursday; drugmakers weigh on healthcare",
      "url": "https://finnhub.io/api/news?id=cc6f316656139ad3db1bb4f27dcf731396a3ccc2e0226af9f8197ed23a2dfcc0"
    }
  },
  {
    "ts": null,
    "headline": "Hims & Hers: The Road To Blue Chip Status",
    "summary": "Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives their best quarter yet.",
    "url": "https://finnhub.io/api/news?id=75e58dc75d9d879a95b8f7e4b162280f81c89bbd11eb86df529c715909eab604",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746697501,
      "headline": "Hims & Hers: The Road To Blue Chip Status",
      "id": 134323823,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1160979827/image_1160979827.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives their best quarter yet.",
      "url": "https://finnhub.io/api/news?id=75e58dc75d9d879a95b8f7e4b162280f81c89bbd11eb86df529c715909eab604"
    }
  },
  {
    "ts": null,
    "headline": "BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit",
    "summary": "BeiGene's innovative cancer treatments, Brukinsa and Tevimbra, are driving growth. Click for a look at ONC and its latest earnings results.",
    "url": "https://finnhub.io/api/news?id=ca884ea3d0ae3c3bfb15c378e648089047409c4bd9deeb85e5a87fafa283d5d6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746696282,
      "headline": "BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit",
      "id": 134323621,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1169172518/image_1169172518.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "BeiGene's innovative cancer treatments, Brukinsa and Tevimbra, are driving growth. Click for a look at ONC and its latest earnings results.",
      "url": "https://finnhub.io/api/news?id=ca884ea3d0ae3c3bfb15c378e648089047409c4bd9deeb85e5a87fafa283d5d6"
    }
  },
  {
    "ts": null,
    "headline": "Down Nearly 20%: Should You Buy the Dip on Eli Lilly?",
    "summary": "Several factors have contributed to Lilly's share price decline, including earnings misses and increased competition.  For a while, it seemed as if Eli Lilly (NYSE: LLY) could do no wrong.  Along the way, Lilly became the largest healthcare company in the world based on market cap.",
    "url": "https://finnhub.io/api/news?id=f6b32a16980150b1fb0d7474a64ff4baa55f66d2477596d1bf9b35c801b502aa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746694260,
      "headline": "Down Nearly 20%: Should You Buy the Dip on Eli Lilly?",
      "id": 134320397,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Several factors have contributed to Lilly's share price decline, including earnings misses and increased competition.  For a while, it seemed as if Eli Lilly (NYSE: LLY) could do no wrong.  Along the way, Lilly became the largest healthcare company in the world based on market cap.",
      "url": "https://finnhub.io/api/news?id=f6b32a16980150b1fb0d7474a64ff4baa55f66d2477596d1bf9b35c801b502aa"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Announces Transitions In Executive Leadership",
    "summary": "Eli Lilly and Co: * LILLY ANNOUNCES TRANSITIONS IN EXECUTIVE LEADERSHIP * ELI LILLY AND CO - ILYA YUFFA APPOINTED EVP AND PRESIDENT,LILLYUSA * ELI LILLY AND...",
    "url": "https://finnhub.io/api/news?id=443affdfd3217c0caa3862750a8198cd7db08fe59054b7b6bd769ba2cb6338af",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746687257,
      "headline": "Eli Lilly Announces Transitions In Executive Leadership",
      "id": 134321566,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Eli Lilly and Co: * LILLY ANNOUNCES TRANSITIONS IN EXECUTIVE LEADERSHIP * ELI LILLY AND CO - ILYA YUFFA APPOINTED EVP AND PRESIDENT,LILLYUSA * ELI LILLY AND...",
      "url": "https://finnhub.io/api/news?id=443affdfd3217c0caa3862750a8198cd7db08fe59054b7b6bd769ba2cb6338af"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Breakfast Podcast: Energy Firms Oppose U.S. Ship Mandate",
    "summary": "U.S. energy firms seek exemption from Trump to transport LNG on U.S.-built ships. China Airlines orders Boeing passenger and freighter models.",
    "url": "https://finnhub.io/api/news?id=5c53f78539fee14ee89577676bc59895803a211b72e4f20e2dea67860a861a6d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746686910,
      "headline": "Wall Street Breakfast Podcast: Energy Firms Oppose U.S. Ship Mandate",
      "id": 134321633,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2174681199/image_2174681199.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "U.S. energy firms seek exemption from Trump to transport LNG on U.S.-built ships. China Airlines orders Boeing passenger and freighter models.",
      "url": "https://finnhub.io/api/news?id=5c53f78539fee14ee89577676bc59895803a211b72e4f20e2dea67860a861a6d"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly and Company, Lilly Cardiometabolic Health and Lilly Usa, Llc Announces Executive Appointments",
    "summary": "Eli Lilly and Company announced executive leadership transitions that will further enhance the company's ability to drive sustained, long-term growth and ensure that its medicines continue to reach...",
    "url": "https://finnhub.io/api/news?id=dc679c43a756c6fc858775da18a66be65b24edc3a23311df9735087a676575ba",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746686700,
      "headline": "Eli Lilly and Company, Lilly Cardiometabolic Health and Lilly Usa, Llc Announces Executive Appointments",
      "id": 134323110,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Eli Lilly and Company announced executive leadership transitions that will further enhance the company's ability to drive sustained, long-term growth and ensure that its medicines continue to reach...",
      "url": "https://finnhub.io/api/news?id=dc679c43a756c6fc858775da18a66be65b24edc3a23311df9735087a676575ba"
    }
  }
]